Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：201501012781296931
Update date: Mar. 16, 2023 Akamatsu Shusuke
Akamatsu Shusuke
ClipsPapers (56)
- Kim S, Thaper D, Bidnur S, Toren P, Akamatsu S, Bishop JL, Colins C, Vahid S, Zoubeidi A. PEG10 is associated with treatment-induced neuroendocrine prostate cancer. Journal of molecular endocrinology. 2019. 63. 1. 39-49
- Li X, Nakayama K, Goto T, Akamatsu S, Shimizu K, Ogawa O, Inoue T. Comparative evaluation of the extraction and analysis of urinary phospholipids and lysophospholipids using MALDI-TOF/MS. Chemistry and physics of lipids. 2019. 223. 104787
- Fujiwara M, Akamatsu S, Sumiyoshi T, Segawa T, Mizuno K, Yoshino T, Goto T, Sawada A, Saito R, Kobayashi T, et al. Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019. 17. 5. e923-e929
- Miyazaki Y, Teramoto Y, Shibuya S, Goto T, Okasho K, Mizuno K, Uegaki M, Yoshikawa T, Akamatsu S, Kobayashi T, et al. Consecutive Prostate Cancer Specimens Revealed Increased Aldo-Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer. Journal of clinical medicine. 2019. 8. 5
- Uegaki M, Kita Y, Shirakawa R, Teramoto Y, Kamiyama Y, Saito R, Yoshikawa T, Sakamoto H, Goto T, Akamatsu S, et al. Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis. Carcinogenesis. 2019. 40. 12. 1535-1544
- Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T. Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation. International journal of clinical oncology. 2019. 24. 10. 1247-1255
- Akamatsu S, Kubota M, Uozumi R, Narita S, Takahashi M, Mitsuzuka K, Hatakeyama S, Sakurai T, Kawamura S, Ishidoya S, et al. Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. European urology oncology. 2019. 2. 3. 320-328
- Hattahara K, Yamasaki T, Sawada A, Tanigaki K, Endo S, Teramoto Y, Banno H, Fuchigami Y, Suzuki R, Fujiwara M, et al. [A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma]. Hinyokika kiyo. Acta urologica Japonica. 2019. 65. 5. 157-161
- Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, Yu Miyazaki, Yuki Makino, Kosuke Okasho, Xin Li, Noriaki Utsunomiya, Takayuki Goto, Takashi Kobayashi, et al. Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer. Scientific reports. 2019. 9. 1. 4030-4030
- Naoki Terada, Toshiyuki Kamoto, Hiromasa Tsukino, Shoichiro Mukai, Shusuke Akamatsu, Takahiro Inoue, Osamu Ogawa, Shintaro Narita, Tomonori Habuchi, Shinichi Yamashita, et al. The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients. BMC cancer. 2019. 19. 1. 156-156
- Tsuneo Saga, Yuji Nakamoto, Takayoshi Ishimori, Takahiro Inoue, Yoichi Shimizu, Hiroyuki Kimura, Shusuke Akamatsu, Takayuki Goto, Hiroyuki Watanabe, Kosuke Kitaguchi, et al. Initial evaluation of PET / CT with 18 F- FSU -880 targeting prostate-specific membrane antigen in prostate cancer patients. Cancer Science. 2019. 110. 2. 742-750
- Shiota M, Narita S, Akamatsu S, Fujimoto N, Sumiyoshi T, Fujiwara M, Uchiumi T, Habuchi T, Ogawa O, Eto M. Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone. JAMA network open. 2019. 2. 2. e190115
- Imai K, Inoue T, Saito R, Goto T, Sawada A, Akamatsu S, Negoro H, Kobayashi T, Terada N, Yamasaki T, et al. [A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments]. Hinyokika kiyo. Acta urologica Japonica. 2019. 65. 1. 13-17
- Negoro H, Inoue T, Imai K, Goto T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Yamasaki T, Ogawa O. Laparoscopic excision of an acquired ureteral diverticulum: A case report. Asian journal of endoscopic surgery. 2018
- Ito K, Takashima Y, Akamatsu S, Terada N, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Negoro H. Intravesical prostatic protrusion is not always the same shape: Evaluation by preoperative cystoscopy and outcome in HoLEP. Neurourology and urodynamics. 2018. 37. 7. 2160-2166
- Kita Y, Goto T, Akamatsu S, Yamasaki T, Inoue T, Ogawa O, Kobayashi T. Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges. Cancers. 2018. 10. 10
- Aizawa R, Takayama K, Nakamura K, Inoue T, Kobayashi T, Akamatsu S, Yamasaki T, Ogawa O, Mizowaki T. Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer. International journal of clinical oncology. 2018. 23. 4. 749-756
- Frees S, Akamatsu S, Bidnur S, Khalaf D, Chavez-Munoz C, Struss W, Eigl BJ, Gleave M, Chi KN, So A. The impact of time to metastasis on overall survival in patients with prostate cancer. World journal of urology. 2018. 36. 7. 1039-1046
- Shusuke Akamatsu, Takahiro Inoue, Osamu Ogawa, Martin E Gleave. Clinical and molecular features of treatment-related neuroendocrine prostate cancer. International Journal of Urology. 2018. 25. 4. 345-351
- Satoshi Funada, Takahisa Kawaguchi, Naoki Terada, Hiromitsu Negoro, Yasuharu Tabara, Shinji Kosugi, Ryo Yamada, Takeo Nakayama, Shusuke Akamatsu, Koji Yoshimura, et al. Cross-Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations. The Journal of urology. 2018. 199. 3. 774-778
Return to Previous Page
